Specialty Pharmacy

The annual rate of 50,000 new HIV infections has not dropped in over a decade.

Significant differences found in the occurrence and type of comorbidity in male and female patients with MS.

Study finds Medicaid health plans need to use a variety of formulary administration techniques and utilization management to limit prescription drug spending.

Specialty drugs comprised 36.5% of the total Medicaid 2015 drug spend.

Some generic brand drugs will continue to dramatically rise, making management through strategic tier placement crucial for continued success.

Medicare Part D Program saved beneficiaries more than $7 billion on medication.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the cost burden of long term care compared with the high cost of short term treatment with specialty drugs.

Gene overexpressed in AML may offer new target for halting the spread of cancer.

Hops in beer contain antibacterial and anti-fungal properties, which could halt the growth of diseases.

Alcohol can affect estrogen in breast cancer cells and weakens the ability of drugs that halt proliferation.

Top stories of the week from The American Journal of Pharmacy Benefits.

Etanercept shows sustained efficacy treating the symptoms of 3 juvenile idiopathic arthritis categories.

Recent advances and updates in oncology and cancer drug development.

Herbal remedies such as stinging nettle, garlic, black cumin, and turmeric can cause harm during chemotherapy in some instances.

Advocacy group helps breast cancer patient overcome fear and channel her anger to battle the disease.

Most read articles of the week on Specialty Pharmacy Times.

New technique uses chromatin as a way of identifying small molecule drugs for cancer.

Preclinical studies of a combination therapy with birinapant and p38 inhibitors show promise treating AML.

Most of MS medications require regular blood tests to track how the drug is affecting the body.

Evomela is the first product to be FDA-approved for a high-dose conditioning indication for multiple myeloma.

By 2018, specialty drugs are expected to account for half of overall US medication spending.

Jury rules in favor of Amgen in trial that challenged the validity of 2 patents on evolocumab (Repatha).

A pilot demonstration will measure the extent of probable fraud in the home health industry

Boosting serotonin may help regulate the immune response to rheumatoid arthritis.

Current standard treatment for advanced ovarian cancer is carboplatin, paclitaxel, and bevacizumab.

Macrophages can penetrate the surrounding walls that protect pancreatic cancer from chemotherapy.

An anti-fraud pilot demonstration is planned for home health agencies in several states.

Research supports weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.